McKesson Corp (MCK) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Earnings ...

McKesson Corp (MCK) reports a 10% revenue increase and raises earnings guidance, despite challenges in the medical surgical ...

McKesson raises 2026 EPS guidance to $38.35–$38.85 while advancing oncology and specialty platforms

Q2 2026 Management View Brian Tyler, CEO, reported "strong second quarter results, which reflect sustained momentum in our ...

McKesson raises annual profit forecast on robust demand for specialty drugs

() -Drug distributor McKesson raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology ...
StockStory.org on MSN

McKesson (NYSE:MCK) Misses Q3 Revenue Estimates

Healthcare distributor and services company McKesson (NYSE:MCK) in Q3 CY2025, but sales rose 10.1% year on year to $103.2 ...

Cardinal Health: Quiet Transformation, Clear Buy

Cardinal Health, Inc. offers a compelling buy with strong gross profit, net income growth and robust free cash flow. Learn ...